Increased levels of tau in CSF have been suggested to reflect neuronal and axonal degeneration [5] whereas reduced CSF levels of Aβ42 might reflect extracellular accumulation of Aβ42 into insoluble senile plaques in the AD brain [6, 7]. The gene discussed is MAPT; the disease is Alzheimer disease.